Related Experiment Video
Updated: Aug 9, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Major depression in 1998: are we providing optimal therapy?
1Department of Psychiatry, Psychiatric University Hospital, Zurich, Switzerland.
Depression is a chronic medical disorder with high recurrence rates, impacting quality of life similarly to diabetes. Optimal treatment strategies are crucial for long-term wellness and recovery.
Area of Science:
- Psychiatry
- Neuroscience
- Public Health
Background:
- Depression is a prevalent, chronic illness with significant morbidity, functional impairment, and suicide risk.
- Lifetime prevalence is ~17%, with over 50% experiencing recurrence, highlighting its chronic nature.
- It's now understood as a chronic medical disorder comparable to hypertension or diabetes in its impact.
Purpose of the Study:
- To review the understanding of depression as a chronic condition.
- To identify predictors of chronicity and recurrence.
- To emphasize the need for optimal treatment strategies focusing on long-term recovery.
Main Methods:
- Literature review and conceptual analysis of depression's chronic nature.
- Identification of risk factors for chronicity and recurrence.
- Discussion of current treatment gaps and future directions.
Main Results:
- Chronicity predictors include episode duration, relationship issues, low income, and hospitalization.
- Recurrence risk factors involve low self-confidence, neuroticism, prior admissions, loss events, and age.
- Despite effective treatments, depression is often underdiagnosed and undertreated.
Conclusions:
- Depression requires chronic disease management strategies for full psychosocial function restoration.
- Future antidepressant treatments should prioritize remission and sustained long-term recovery.
- Addressing underdiagnosis and undertreatment is essential for managing this chronic condition.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
13:18Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Related Concept Videos
G-protein Coupled Receptors
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...